Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.730
+0.030 (1.11%)
At close: Oct 31, 2024, 4:00 PM
2.860
+0.130 (4.76%)
After-hours: Oct 31, 2024, 4:29 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $194.12 million as of October 31, 2024. Its market cap has decreased by -85.34% in one year.
Market Cap
194.12M
Enterprise Value
-188.23M
1-Year Change
-85.34%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $762.70M to $194.12M, a decrease of -74.55%. That is a compound annual growth rate of -25.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 192.00M | -82.09% |
Dec 29, 2023 | 1.07B | -6.73% |
Dec 30, 2022 | 1.15B | -69.82% |
Dec 31, 2021 | 3.81B | 80.54% |
Dec 31, 2020 | 2.11B | 176.58% |
Apr 3, 2020 | 762.70M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lifecore Biomedical | 206.97M |
Semler Scientific | 206.76M |
Atai Life Sciences | 204.71M |
Fulcrum Therapeutics | 202.18M |
Organigram Holdings | 201.57M |
Cabaletta Bio | 200.28M |
Corbus Pharmaceuticals Holdings | 196.80M |
Kodiak Sciences | 195.78M |